Prot #AG CLI-0206: A Phast 3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AMG0001 in Subjects with Critical Limb Ischemia

Project: Research project

Project Details

StatusFinished
Effective start/end date4/10/15 → 4/10/18

Funding

  • Quintiles, Inc. (AG CLI-0206 // AG CLI-0206)
  • AnGes, Inc. (AG CLI-0206 // AG CLI-0206)